The study included two years of data from 268 patients across three hospitals in Greece. Patients received epinephrine and either vasopressin or a placebo during CPR. Patients who received vasopressin had an 83.9 percent probability of returning to spontaneous circulation compared to the 65.9 percent probability of returning to spontaneous circulation of the other group.
In addition, 13.1 percent of patients who received vasopressin were alive and had a favorable neurological recovery compared to just 5.1 percent of patients in the control group.
More Articles on Quality:
6 Steps to Lower Heart Failure Readmissions
Reducing Preventable Birth Injuries Through Evidence-Based Care, Enhanced Teamwork
Infographic: Communication Gaps From Outdated Technology Pose Threats, Costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
